Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO Applauds the U.S. House of Representatives for Passage of the American Research and Competitiveness Act

May 21 2015
By making this tax credit permanent, companies conducting their development programs will be able to estimate their tax liability and will not be burdened by the constant uncertainty regarding whether or not the R&D Tax Credit will be extended.

EPA Should Reissue the 2014 RFS Proposal Consistent with the Statute, BIO Says

May 19 2015
It is imperative that the Environmental Protection Agency gets the administration of the annual Renewable Fuel Standard (RFS) renewable volume obligations (RVOs) back on track, BIO wrote today.

Solazyme CEO Jonathan S. Wolfson to Receive the 2015 BIO George Washington Carver Award

May 19 2015
The Biotechnology Industry Organization (BIO) named Solazyme CEO and co-founder Jonathan S. Wolfson as the recipient of its 2015 George Washington Carver Award for innovation in industrial biotechnology. Wolfson will receive the award and give a brief talk at the upcoming BIO World Congress on Industrial Biotechnology in July in Montreal, Canada. 

BIO and Aon Join Forces to Offer Members Executive Liability Protection through BIO Business Solutions

May 13 2015

...

Washington Governor Inslee Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

May 13 2015
Governor Inslee signed Senate Bill 5935 into law on Monday. The Washington Senate passed the legislation in April with a vote of 47-1, preceded by a vote of 96-1 on the same bill in the House.

BIO and Aon Join Forces to Offer Members Executive Liability Protection through BIO Business Solutions

May 13 2015
By teaming up with Aon, we are able to offer our members state-of-the-art coverage enhancements specific for life sciences companies...

2015 BIO International Convention to Feature Expanded Innovation Zone with NIH and NSF Small Business Innovation Research Companies

May 11 2015
Washington, D.C. (May 11, 2015) – The Biotechnology Industry Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR) funded early-stage biomedical companies in an expanded Innovation Zone at the 2015 BIO International Convention®. The Innovation Zone companies, focused on drug discovery, diagnostics and other therapeutic platform technologies, will have dedicated exhibit space and participate in BIO One-on-One Partnering™. Select companies will make 15-minute company presentations in the BIO Business Forum. The Innovation Zone will also feature six universities funded under the prestigious NSF Accelerating Innovation Research Program (AIR). This select group will demonstrate advanced biomedical prototypes that are very close to commercialization stage.  

LanzaTech CEO Holmgren Selected to receive the 2015 BIO Rosalind Franklin Award

May 8 2015
Washington, D.C. (May 08, 2015) – The Biotechnology Industry Organization (BIO)  announced today  that  Dr. Jennifer Holmgren, Chief Executive Officer of the innovative carbon recycling company LanzaTech, has been selected by a committee of her peers to be the recipient of the 2015 BIO Rosalind Franklin Award. The Rosalind Franklin Award was established by BIO to honor an outstanding woman in the field of industrial biotechnology. 

Tennessee Governor Haslam Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

May 7 2015
BIO and Life Science Tennessee commend Governor Bill Haslam for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.

BIO Applauds the Securities and Exchange Commission for Finalizing Tick Size Pilot Program

May 7 2015
Program will improve liquidity and enhance capital formation for emerging biotech companies